kff employer health benefits survey 2025 glp-1 coverage In recent interviews and focus groups with employers about covering drugs for weight loss, we learned that, while more large employers are covering them, virtually all employers highlighted cost challenges. Many A new car vs. health
Description
T, testosterone

Lisdexamfetamine (Vyvanse) is the only medication specifically approved for moderate to severe BED in adults, while GLP-1 agonists may be prescribed off-label based on emerging evidence
Conversely, the LIRAFLAME trial failed to show a significant effect of liraglutide compared to placebo on vascular inflammation as assessed by [18F]FDG PET after 26 weeks of treatment in people with T2DM [140]

Patients with type 2 diabetes, especially those with cardiovascular disease, chronic kidney disease, obesity, or NAFLD, may benefit from GLP-1 receptor agonists as part of their treatment regimen
Rena G, Hardie DG, Pearson ER

In many cases, additional medical documentation, updated laboratory results, or provider recommendations may support a successful appeal
